Skip to main content

Table 3 Secondary outcomes

From: Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial

Outcome

AN69ST

(n = 26)

PMMA

(n = 26)

AN69ST vs. PMMA

Unadjusted 95% CI

Adjusted a 95% CI

Unadjusted P value

Adjusted a P value

ICU mortality, n (%)

13 (50.0)

9 (34.6)

1.89 (0.62–5.76)

1.65 (0.48–5.85)

0.40

0.42

28-day all-cause mortality, n (%)

13 (50.0)

8 (30.8)

2.00 (0.67–6.23)

2.34 (0.67–8.72)

0.22

0.18

ICUFDs, median (IQR)

0 (0–18.3)

0 (0–16.0)

0.99 (0.93–1.05)

–

0.65

–

VAI at 48 h after CRRT initiation, median (IQR)

0 (0–8.4)

0 (0–15.0)

1.01 (0.99–1.05)

–

0.32

–

P/F ratio at 48 h after CRRT initiation, median (IQR)

220 (61.4–321.0)

227 (91.5–308)

1.00 (0.99–1.00)

–

0.71

–

  1. AN69ST polyethyleneimine-coated polyacrylonitrile, PMMA polymethylmethacrylate, CI confidence interval, ICU intensive care unit, ICUFDs ICU-free days, IQR interquartile range; CRRT continuous renal replacement therapy, VAI vasopressor index, P/F partial pressure of arterial oxygen/fraction of inspired oxygen
  2. aAnalyzed by multilogistic regression model and explanatory variables such as age and SOFA score